Our analysis of TERT gene variations in liver cancer patients using the TCGA database revealed that amplification of the TERT gene occurred in only ~4% (23/587) of the liver cancer patients (Fig. S2A), which was consistent with the studies by other groups30,41. Here, TERT is linked to liver cancer.